|
1
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L, Parkin DM, Ferlay J, Li L and Chen
Y: Estimates of cancer incidence in China for 2000 and projections
for 2005. Cancer Epidemiol Biomarkers Prev. 14:243–250.
2005.PubMed/NCBI
|
|
4
|
Zhou XD, Wang XY, Qu FJ, et al: Detection
of cancer stem cells from the C6 glioma cell line. J Int Med Res.
37:503–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiu B, Zhang D, Tao J, Wu A and Wang Y: A
simplified and modified procedure to culture brain glioma stem
cells from clinical specimens. Oncol Lett. 3:50–54. 2012.PubMed/NCBI
|
|
6
|
Hwang-Verslues WW, Kuo WH, Chang PH, et
al: Multiple lineages of human breast cancer stem/progenitor cells
identified by profiling with stem cell markers. PLoS One.
4:e83772009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen W and Wang GM: Gene expression
profiling of cancer stem cells in the Du145 prostate cancer cell
line. Oncol Lett. 3:791–796. 2012.PubMed/NCBI
|
|
8
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
9
|
Suetsugu A, Nagaki M, Aoki H, Motohashi T,
Kunisada T and Moriwaki H: Characterization of CD133+
hepatocellular carcinoma cells as cancer stem/progenitor cells.
Biochem Biophys Res Commun. 351:820–824. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Varnat F, Duquet A, Malerba M, et al:
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI
signalling that is essential for tumour growth, recurrence,
metastasis and stem cell survival and expansion. EMBO Mol Med.
1:338–351. 2009. View Article : Google Scholar
|
|
11
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sullivan JP, Minna JD and Shay JW:
Evidence for self-renewing lung cancer stem cells and their
implications in tumour initiation, progression, and targeted
therapy. Cancer Metastasis Rev. 29:61–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Otto WR: Lung epithelial stem cells. J
Pathol. 197:527–535. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rawlins EL and Hogan BL: Epithelial stem
cells of the lung: privileged few or opportunities for many?
Development. 133:2455–2465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang
J: The side population in human lung cancer cell line NCI-H460 is
enriched in stem-like cancer cells. PLoS One. 7:e333582012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meng M, Zhao XH, Ning Q, Hou L, Xin GH and
Liu LF: Tumor stem cells: A new approach for tumor therapy
(Review). Oncol Lett. 4:187–193. 2012.PubMed/NCBI
|
|
17
|
Kim CF, Jackson EL, Woolfenden AE, et al:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eramo A, Lotti F, Sette G, et al:
Identification and expansion of the tumorigenic lung cancer stem
cell population. Cell Death Differ. 15:504–514. 2008. View Article : Google Scholar
|
|
20
|
Groome PA, Bolejack V, Crowley JJ, et al:
IASLC International Staging Committee; Cancer Research and
Biostatistics; Observers to the Committee; Participating
Institutions: The IASLC Lung Cancer Staging Project: validation of
the proposals for revision of the T, N, and M descriptors and
consequent stage groupings in the forthcoming (seventh) edition of
the TNM clas-sification of malignant tumors. J Thorac Oncol.
2:694–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong QG, Yao M, Geng Q, Zhou J and Yan MX:
Isolation and identification of human lung adenocarcinoma stem
cells. Tumor. 28:1–7. 2008.(In Chinese).
|
|
22
|
Bertolini G, Roz L, Perego P, et al:
Highly tumorigenic lung cancer CD133+ cells display stem-like
features and are spared by cisplatin treatment. Proc Natl Acad Sci
USA. 106:16281–16286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dean M: ABC transporters, drug resistance,
and cancer stem cells. J Mammary Gland Biol Neoplasia. 14:3–9.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sung JM, Cho HJ, Yi H, et al:
Characterization of stem cell population in lung cancer A549 cells.
Biochem Biophys Res Commun. 371:163–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Levina V, Marrangoni AM, DeMarco R,
Gorelik E and Lokshin AE: Drug-selected human lung cancer stem
cells: cytokine network, tumorigenic and metastatic properties.
PLoS One. 3:e30772008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Omary MB, Coulombe PA and McLean WH:
Intermediate filament proteins and their associated diseases. New
Engl J Med. 351:2087–2100. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fukunaga Y, Bandoh S, Fujita J, et al:
Expression of cytokeratin 8 in lung cancer cell lines and
measurement of serum cytokeratin 8 in lung cancer patients. Lung
Cancer. 38:31–38. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kanaji N, Bandoh S, Fujita J, Ishii T,
Ishida T and Kubo A: Compensation of type I and type II cytokeratin
pools in lung cancer. Lung Cancer. 55:295–302. 2007. View Article : Google Scholar
|
|
29
|
Ghotra VP, Puigvert JC and Danen EH: The
cancer stem cell microenvironment and anti-cancer therapy. Int J
Radiat Biol. 85:955–962. 2009. View Article : Google Scholar : PubMed/NCBI
|
